In Vitro Diagnostics firm Medsource Ozone raises $4.7 M from Xponentia Capital

Faridabad-based In Vitro Diagnostics (IVD) manufacturer Medsource Ozone Biomedicals has raised INR 35 Cr ($4.7 M) in an equity round from Xponentia Capital (via Xponentia Opportunities Fund 1). Xponentia Capital subscribed to 95,803 equity shares at an issue price of INR 3,653.33. Regulatory filings also show a secondary transfer of 13,686 equity shares from the promoters. Xponentia will hold 6.9% stake in the company post the transaction. Medsource Ozone had reported a turnover of INR 78.18 Cr in the last fiscal year. Its EBITDA and PAT values stood at INR 10.30 Cr and INR 6.89 Cr respectively.